Showing results (191-200 of 240) with videos related to

Sort By:
Pageof 24
Journal of Dental Research|March 13, 2025
Cargo-less Nanoparticles Prevent Bone Loss in Periodontitis and Peri-implantitisM H A Saleh, A Roh, K Martin, et al.
Oncotarget|November 16, 2017
Synergistic effect of eribulin and CDK inhibition for the treatment of triple negative breast cancerShreyas S Rao, Jenna Stoehr, Danijela Dokic, et al.
Breast Cancer Research and Treatment|February 22, 2023
Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPALM Thill, M-O Zahn, A Welt, et al.
The Journal of Experimental Medicine|April 1, 1996
The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaBH L Pahl, B Krauss, K Schulze-Osthoff, et al.
The Review of Scientific Instruments|December 3, 2016
The National Ignition Facility modular Kirkpatrick-Baez microscopeL A Pickworth, J Ayers, P Bell, et al.
Nature Communications|August 8, 2023
A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungsJing Wang, Ramon Ocadiz-Ruiz, Matthew S Hall, et al.
Clinical & Experimental Metastasis|August 24, 2022
Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancerSophia M Orbach, Michael D Brooks, Yining Zhang, et al.
ESMO Real World Data and Digital Oncology|April 20, 2026
Unmet need for patients with metastatic triple-negative breast cancer initiating first-line treatment: data from the prospective German tumor registry OPALE Stickeler, T Decker, M-O Zahn, et al.
The Review of Scientific Instruments|November 29, 2014
A Kirkpatrick-Baez microscope for the National Ignition FacilityL A Pickworth, T McCarville, T Decker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2012
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306S Stintzing, L Fischer von Weikersthal, T Decker, et al.
Pageof 24